Sign in
Taking people in South KoreaNo phase

LEXURE Digital Language Training for Post-Stroke Aphasia

Tests a digital language training app against workbook exercises in adults with aphasia after stroke.

Key facts

Who runs it
Nunaps Inc
Where
Ansan, Busan, Chuncheon, Daegu, Gwangju, Ilsan, Jeonju, Seoul, and Ulsan, South KoreaSee the 12 sites
Trial code
Registry title
LEXURE for Post-Stroke Aphasia
Status
Recruiting
People taking part
116 people, planned
Started
16 Apr 2026
Expected to end
30 Dec 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • LEXURE
  • Workbook
Record updated
14 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who have had a stroke at least 3 months ago and now have aphasia (a language problem). It compares an app-based language training with workbook-based training.

Age
19 years or older
Sex
All sexes can join.
Disease stage
Stroke (bleeding or clot type) at least 3 months ago, with aphasia caused by the stroke. Aphasia Quotient score between 26 and 90 (inclusive) on the K-WAB or PK-WAB-R test.
Earlier treatment
People currently getting speech-language therapy or taking part in another language-related trial cannot join.

Main reasons for not taking part

  • Language problem caused by something other than stroke (for example brain injury, brain tumor or a brain disease that gets worse over time)
  • Language problem from a developmental disorder
  • Currently getting speech-language therapy or in another language-related trial
  • Taking medicine for a severe psychiatric disorder
  • Cannot read or write, or has severe cognitive impairment

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Diagnosed with hemorrhagic or ischemic stroke
  • At least 3 months have elapsed since stroke onset
  • History of aphasia resulting from stroke
  • Aphasia Quotient (AQ) score between 26 and 90 (inclusive) on the Korean version of the Western Aphasia Battery (K-WAB) or the Paradise Korean version of the Western Aphasia Battery-Revised (PK-WAB-R)
  • Adults aged 19 years or older
  • Native Korean speakers
  • Able to use the investigational device or perform workbook-based training without difficulty
  • Willing to participate voluntarily and provide written informed consent

Who cannot take part

  • Currently receiving speech-language therapy or participating in another clinical trial related to language function
  • Currently receiving medication for severe psychiatric disorders (e.g., bipolar disorder, major depressive disorder, schizophrenia, alcohol dependence, or substance abuse)
  • Diagnosed with language impairment due to causes other than stroke (e.g., traumatic brain injury, brain tumor, or neurodegenerative disease)
  • History of language impairment due to developmental disorders
  • Severe cognitive impairment that would interfere with understanding or performing the study interventions
  • Illiterate individuals
  • Individuals deemed unsuitable for participation in this study by the investigator

Where in South Korea

  • Korea University Ansan HospitalAnsan, South KoreaContact: Jin-Man Jung, MD, PhDNot yet recruiting
  • Inje University Busan Paik HospitaBusan, South KoreaContact: Eung-Gyu Kim, MD, PhDTaking people
  • Hallym University Chuncheon Sacred Heart HospitalChuncheon, South KoreaContact: Chulho Kim, MD, PhDTaking people
  • Keimyung University Dongsan HospitalDaegu, South KoreaContact: Sung Il Sohn, MD, PhDTaking people
  • Kyungpook National University HospitalDaegu, South KoreaContact: Yangha Hwang, MD, PhDNot yet recruiting
  • Yeungnam University Medical CenterDaegu, South KoreaContact: Jun Lee, MD, PhDNot yet recruiting
  • Chonnam National University HospitalGwangju, South KoreaContact: Man Seok Park, MD, PhDTaking people
  • Inje University Ilsan Paik HospitalIlsan, South KoreaContact: Keun-Sik Hong, MD, PhDTaking people
  • jeonbuk National University HospitalJeonju, South KoreaContact: Hyun Goo Kang, MD, PhDNot yet recruiting
  • Asan Medical CenterSeoul, South KoreaContact: Jun Young Chang, MD, PhDTaking people
  • Konkuk University Medical CenterSeoul, South KoreaContact: Hahn Young Kim, MD, PhDTaking people
  • Ulsan University HospitalUlsan, South KoreaContact: Jee-Hyun Kwon, MD, PhDTaking people

About the trial

What the trial wants to find out

This study evaluates the efficacy of digital language rehabilitation using LEXURE for the treatment of post-stroke aphasia. Half of participants will receive structured language training using the LEXURE application, while the other half will receive workbook-based language training as an active comparator.

The 2 groups in the trial

  • LEXURETreatment being tested

    Participants assigned to this arm will receive language training intervention using the LEXURE digital therapeutic (DTx) software.

  • WorkbookExisting treatment, for comparison

    Participants assigned to this arm will receive a language therapy workbook and perform structured language exercises as a control intervention.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Prospective, Multicenter, Randomized, Evaluator-Blinded, Confirmatory Study to Evaluate the Efficacy and Safety of LEXURE for Improving Language Function in Patients With Post-Stroke Aphasia
Plain-language title
LEXURE Digital Language Training for Post-Stroke AphasiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
14 May 2026